Andrew James Marshall

Title: The Innovations of Andrew James Marshall

Introduction

Andrew James Marshall is an accomplished inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic heterocyclic compounds. His research focuses on developing compounds that have kinase inhibitory activity, which can be crucial in treating various diseases.

Latest Patents

Marshall holds a patent for "Tricyclic heterocyclic derivatives and uses thereof." This patent discloses tricyclic heterocyclic compounds that exhibit kinase inhibitory activity. The compounds are designed for use in pharmaceutical compositions and kits, aimed at treating a range of diseases and conditions. Notably, these compounds target CSF-1R (c-FMS kinase) and are intended for the treatment of proliferative or neoplastic diseases, including cancers, as well as bone, inflammatory, and autoimmune diseases.

Career Highlights

Andrew James Marshall is associated with Auckland Uniservices Limited, where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, particularly in the treatment of serious health conditions.

Collaborations

Marshall collaborates with notable colleagues, including Swarnalatha Akuratiya Gamage and Peter Robin Shepherd. These partnerships enhance the research and development process, fostering innovation in the field.

Conclusion

Andrew James Marshall's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work on tricyclic heterocyclic compounds showcases the potential for advancements in treating various diseases.